[{"id":"24653085-881e-4903-a522-c30baa886f8e","acronym":"TEM-GBM","url":"https://clinicaltrials.gov/study/NCT03866109","created_at":"2021-07-05T17:20:43.739Z","updated_at":"2024-07-02T16:35:57.223Z","phase":"Phase 1/2","brief_title":"A Study Evaluating Temferon in Patients With Glioblastoma \u0026 Unmethylated MGMT","source_id_and_acronym":"NCT03866109 - TEM-GBM","lead_sponsor":"Genenta Science","biomarkers":" MGMT","pipe":"","alterations":" ","tags":["MGMT"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Temferon (Autologous CD34+ enriched HSPCs expressing interferon-alpha 2)"],"overall_status":"Recruiting","enrollment":" Enrollment 27","initiation":"Initiation: 03/05/2019","start_date":" 03/05/2019","primary_txt":" Primary completion: 12/01/2023","primary_completion_date":" 12/01/2023","study_txt":" Completion: 12/01/2024","study_completion_date":" 12/01/2024","last_update_posted":"2023-01-20"}]